David Beckham's Prenetics Halts Bitcoin Purchases, Shifts Focus to Wellness Brand IM8

David Beckham's Prenetics Halts Bitcoin Purchases, Shifts Focus to Wellness Brand IM8

N
News Editor 01
2026-07-02 20:45:14
Prenetics Global Limited, a Nasdaq-listed health sciences company, has ended its daily bitcoin purchase program and is redirecting all capital and strategic focus toward IM8, a consumer health and longevity brand co-founded with David Beckham. The company retains 510 bitcoin as a treasury reserve but will not acquire more. IM8 reached $100 million in annualized recurring revenue within 11 months and is projected to generate $180-$200 million in fiscal 2026. The move comes as bitcoin struggles amid weak market sentiment, reflecting a broader trend of public companies returning to core business operations.
PreneticsBitcoinBitcoin Purchases HaltedDavid BeckhamIM8Wellness BrandCapital AllocationCrypto Treasury

End of Bitcoin Purchases, Capital Shift to Wellness Brand

Nasdaq-listed health sciences company Prenetics Global Limited has announced the termination of its bitcoin purchase program, redirecting all capital and strategic focus entirely toward IM8, a fast-growing consumer health and longevity brand co-founded with David Beckham. The company ceased daily bitcoin purchases on December 4 following board approval and will not pursue future cryptocurrency acquisitions. However, Prenetics will retain its existing holdings of 510 bitcoin as a treasury reserve asset but has committed not to allocate any new or existing capital toward expanding that position.

The move marks a clear shift from a strategy adopted earlier this year, when several public firms began accumulating bitcoin as a treasury asset during a rising market. That trend has slowed in recent months as cryptocurrency prices weakened and investor focus returned to core operating businesses.

IM8's Explosive Growth Drives the Pivot

Prenetics said the decision reflects the rapid growth of IM8, which it described as the fastest-growing supplement brand in industry history. IM8 surpassed $100 million in annualized recurring revenue within 11 months of launch and is projected to generate between $180 million and $200 million in revenue in fiscal year 2026. Danny Yeung, CEO and co-founder of Prenetics, stated: 'The phenomenal success of IM8 has exceeded all expectations and scaled much faster than our original expectations.' Management and the board agreed that concentrating resources on IM8 offered the clearest path to long-term shareholder value.

Under the revised capital allocation strategy, funds will be directed exclusively toward IM8's operations and expansion, including product development, brand marketing, talent acquisition, working capital, and international growth initiatives. The company framed the shift as an effort to sharpen strategic clarity and reinforce disciplined governance.

Strong Financial Position: $70M Cash, Zero Debt, Bitcoin Intact

Prenetics said it remains in a strong financial position with more than $70 million in cash and cash equivalents, zero debt, and its existing bitcoin holdings intact. The company's balance sheet strength gives it flexibility to fund IM8's next phase of growth without relying on external financing. IM8 markets an all-in-one nutritional supplement aimed at simplifying daily health routines. The brand has been promoted by Beckham and tennis world number one Aryna Sabalenka, and Prenetics has leaned heavily into celebrity-backed branding as it scales globally.

Bitcoin Market Headwinds and Company Response

The decision to halt bitcoin purchases comes as the digital asset market faces a period of weaker sentiment. Bitcoin has struggled to regain momentum after a sharp downturn earlier in the year, and several companies that adopted crypto-heavy treasury strategies have seen their share prices come under pressure. Against that backdrop, Prenetics' move stands out as a reversion toward a more traditional operating focus. When the company announced its bitcoin accumulation strategy in June, Yeung spoke about the potential overlap between healthcare innovation and blockchain technology. Six months later, the company's tone has shifted, emphasizing execution, revenue growth, and consumer demand.

Prenetics said it believes the updated strategy aligns the company more closely with shareholder priorities as IM8 continues to scale. While bitcoin will remain on the balance sheet, the company made clear it will no longer play a central role in its capital deployment plans. Shares of Prenetics were little changed following the announcement, trading at $16.42 at time of writing. Bitcoin is currently trading at $88,626, up 1% over the past 24 hours on $39 billion in volume, with a market cap of about $1.77 trillion. The price sits near the top of its weekly range, with nearly 19.97 million BTC currently in circulation.

This article was originally published by Bit.Fan. For more cryptocurrency news and market insights, visit www.bit.fan.
200

Disclaimer:

The market information, project data, and third-party content displayed on this platform are for industry information sharing only and do not constitute any form of investment advice or return commitment.

Cryptocurrency trading carries high risks. Users should fully assess their risk tolerance and make independent decisions. All profits, losses, and legal responsibilities are borne by the users themselves.